Deep learning-based classification of kidney transplant pathology: a retrospective, multicentre, proof-of-concept study

Kers, J.; Bulow, R.D.; Klinkhammer, B.M.; Breimer, G.E.; Fontana, F.; Abiola, A.A.; ... ; Boor, P. (2022)

Article / Letter to editor

Background Histopathological assessment of transplant biopsies is currently the standard method to diagnose allograft rejection and can help guide patient management, but it is one of the most challenging areas of pathology, requiring considerable expertise, time, and effort. We aimed to analyse the utility of deep learning to preclassify histology of kidney allograft biopsies into three main broad categories (ie, normal, rejection, and other diseases) as a potential biopsy triage system focusing on transplant rejection.Methods We performed a retrospective, multicentre, proof-of-concept study using 5844 digital whole slide images of kidney allograft biopsies from 1948 patients. Kidney allograft biopsy samples were identified by a database search in the Departments of Pathology of the Amsterdam UMC, Amsterdam, Netherlands (1130 patients) and the University Medical Center Utrecht, Utrecht, Netherlands (717 patients). 101 consecutive kidney transplant biopsies were identified in the archive of the Institute of Pathology, RWTH Aachen University Hospital, Aachen, Germany. Convolutional neural networks (CNNs) were trained to classify allograft biopsies as normal, rejection, or other diseases. Three times cross-validation (1847 patients) and deployment on an external real-world cohort (101 patients) were used for validation. Area under the receiver operating characteristic curve (AUROC) was used as the main performance metric (the primary endpoint to assess CNN performance).Findings Serial CNNs, first classifying kidney allograft biopsies as normal (AUROC 0.87 [ten times bootstrapped CI 0.85-0.88]) and disease (0.87 [0.86-0.88]), followed by a second CNN classifying biopsies classified as disease into rejection (0.75 [0.73-0.76]) and other diseases (0.75 [0.72-0.77]), showed similar AUROC in cross-validation and deployment on independent real-world data (first CNN normal AUROC 0.83 [0.80-0.85], disease 0.83 [0.73-0.91]; second CNN rejection 0.61 [0.51-0.70], other diseases 0.61 [0.50-4.74]). A single CNN classifying biopsies as normal, rejection, or other diseases showed similar performance in cross-validation (normal AUROC 0.80 [0.73-0.84], rejection 0.76 [0.66-0.80], other diseases 0.50 [0.36-0.57]) and generalised well for normal and rejection classes in the real-world data. Visualisation techniques highlighted rejection-relevant areas of biopsies in the tubulointerstitium.Interpretation This study showed that deep learning-based classification of transplant biopsies could support pathological diagnostics of kidney allograft rejection. Copyright (C) 2021 The Author(s). Published by Elsevier Ltd.

• All authors: Kers, J.; Bulow, R.D.; Klinkhammer, B.M.; Breimer, G.E.; Fontana, F.; Abiola, A.A.; Hofstraat, R.; Corthals, G.L.; Peters-Sengers, H.; Djudjaj, S.; Stillfried, S. von; Holscher, D.L.; Pieters, T.T.; Zuilen, A.D. van; Bemelman, F.J.; Nurmohamed, A.S.; Naesens, M.; Roelofs, J.J.T.H.; Florquin, S.; Floege, J.; Nguyen, T.Q.; Kather, J.N.; Boor, P.
• Date: 2022-01-01
• Journal: The Lancet Digital Health
• Volume: 4
• Issue: 1
• Pages: 18 - 26
• DOI: doi:10.1016/S2589-7500(21)00211-9
• Link: https://www.sciencedirect.com/science/article/pii/S2589750021002119?via%...